##plugins.themes.bootstrap3.article.main##

Félix Ayala-Peralta Dasio Ayala-Moreno Antonio Luna-Figueroa César Carranza-Asmat Emma Ysabel Quiñones-Pereyra Richard Ayala-Palomino Luis Alberto Quiñones-Vásquez Jovanna Ochante-Rementería

Abstract

The genitourinary syndrome of menopause clinically is evident 4 to 5 years after menopause, and objective changes are
present in 25-50% of all postmenopausal women. The most frequent symptoms are vaginal dryness ( 75%), dyspareunia
(38%), and vaginal itching, vaginal discharge and pain (15%); and the diagnosis is based on clinical criteria. The principles
therapeutic are based on the restoration of urogenital physiology and relief of symptoms; including non-hormonal / lubricant
therapeutic options, systemic hormonal therapy, local estrogen therapy and other alternatives. The genitourinary syndrome
of menopause is one of the most important determinants of sexual function and urogenital health, with a significant impact on
the quality of life related to female health.

Downloads

Download data is not yet available.

##plugins.themes.bootstrap3.article.details##

Section
Review

How to Cite

Ayala-Peralta, F., Ayala-Moreno, D., Luna-Figueroa, A., Carranza-Asmat, C., Quiñones-Pereyra, E. Y., Ayala-Palomino, R., Quiñones-Vásquez, L. A., & Ochante-Rementería, J. (2017). Genitourinary Syndrome Of Menopause: Clinic And Management. Revista Peruana De Investigación Materno Perinatal, 6(1), 66–73. https://doi.org/10.33421/inmp.201780

Most read articles by the same author(s)

1 2 3 > >>